AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, G.
Right arrow Articles by Kris-Etherton, P. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, G.
Right arrow Articles by Kris-Etherton, P. M
Agricola
Right arrow Articles by Zhao, G.
Right arrow Articles by Kris-Etherton, P. M
American Journal of Clinical Nutrition, Vol. 85, No. 2, 385-391, February 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Dietary {alpha}-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects1,2,3

Guixiang Zhao, Terry D Etherton, Keith R Martin, Peter J Gillies, Sheila G West and Penny M Kris-Etherton

1 From the Departments of Nutritional Sciences (GZ, TDE, KRM, and PMK-E), Dairy and Animal Science (TDE), and Biobehavioral Health (SGW), The Pennsylvania State University, University Park, PA, and the DuPont Haskell Laboratory for Health and Environmental Sciences, Newark, DE (PJG)

Background:Atherosclerosis is a chronic inflammatory disease. We previously reported that a diet high in {alpha}-linolenic acid (ALA) reduces lipid and inflammatory cardiovascular disease risk factors in hypercholesterolemic subjects.

Objective:The objective was to evaluate the effects of a diet high in ALA on serum proinflammatory cytokine concentrations and cytokine production by cultured peripheral blood mononuclear cells (PBMCs) from subjects fed the experimental diets.

Design:A randomized, controlled, 3-diet, 3-period crossover study design was used. Hypercholesterolemic subjects (n = 23) were assigned to 3 experimental diets: a diet high in ALA (ALA diet; 6.5% of energy), a diet high in linoleic acid (LA diet; 12.6% of energy), and an average American diet (AAD) for 6 wk. Serum interleukin (IL)-6, IL-1ß, and tumor necrosis factor-{alpha} (TNF-{alpha}) concentrations and the production of IL-6, IL-1ß, and TNF-{alpha} by PBMCs were measured.

Results:IL-6, IL-1ß, and TNF-{alpha} production by PBMCs and serum TNF-{alpha} concentrations were lower (P < 0.05 and P < 0.08, respectively) with the ALA diet than with the LA diet or AAD. PBMC production of TNF-{alpha} was inversely correlated with ALA (r = –0.402, P = 0.07) and with eicosapentaenoic acid (r = –0.476, P = 0.03) concentrations in PBMC lipids with the ALA diet. Changes in serum ALA were inversely correlated with changes in TNF-{alpha} produced by PBMCs (r = –0.423, P < 0.05).

Conclusions:Increased intakes of dietary ALA elicit antiinflammatory effects by inhibiting IL-6, IL-1ß, and TNF-{alpha} production in cultured PBMCs. Changes in PBMC ALA and eicosapentaenoic acid (derived from dietary ALA) are associated with beneficial changes in TNF-{alpha} release. Thus, the cardioprotective effects of ALA are mediated in part by a reduction in the production of inflammatory cytokines.

Key Words: Hypercholesterolemic subjects • {alpha}-linolenic acid • eicosapentaenoic acid • interleukin-6 • interleukin-1ß • tumor necrosis factor-{alpha} • peripheral blood mononuclear cells




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
D. K Banel and F. B Hu
Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review
Am. J. Clinical Nutrition, July 1, 2009; 90(1): 56 - 63.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Ros
Nuts and novel biomarkers of cardiovascular disease
Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1649S - 1656S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. H. Garman, S. Mulroney, M. Manigrasso, E. Flynn, and C. Maric
Omega-3 fatty acid rich diet prevents diabetic renal disease
Am J Physiol Renal Physiol, February 1, 2009; 296(2): F306 - F316.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
B M Yashodhara, S Umakanth, J M Pappachan, S K Bhat, R Kamath, and B H Choo
Omega-3 fatty acids: a comprehensive review of their role in health and disease
Postgrad. Med. J., February 1, 2009; 85(1000): 84 - 90.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Esmaillzadeh and L. Azadbakht
Home use of vegetable oils, markers of systemic inflammation, and endothelial dysfunction among women
Am. J. Clinical Nutrition, October 1, 2008; 88(4): 913 - 921.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. P. Simopoulos
The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases
Experimental Biology and Medicine, June 1, 2008; 233(6): 674 - 688.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Marion-Letellier, M. Butler, P. Dechelotte, R. J Playford, and S. Ghosh
Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor {gamma} ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor {gamma} in intestinal inflammation
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 939 - 948.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
S. Badiou, J.-P. Cristol, I. Jaussent, N. Terrier, M. Morena, F. Maurice, H. Leray-Moragues, J.-P. Rivory, L. Chalabi, C. Delcourt, et al.
Fine-Tuning of the Prediction of Mortality in Hemodialysis Patients by Use of Cytokine Proteomic Determination
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 423 - 430.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. H. Lee, J. H. O'Keefe, C. J. Lavie, R. Marchioli, and W. S. Harris
Omega-3 Fatty Acids for Cardioprotection
Mayo Clin. Proc., March 1, 2008; 83(3): 324 - 332.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition